Johnson & Johnson (JNJ) is preparing next year to spin off its consumer health unit into a publicly traded company separate from its pharmaceutical and medical technology operations. Ahead of the ...
Tag: Bristol-Myers Squibb Co
An S&P 500 ETF delivering double-digit percentage dividends
Investors may want to consider JPMorgan’s Equity Premium Income Fund ETF in order to get more reliable gains in the current volatile market environment. According to the firm, the ETF uses S&...
Jim Cramer makes the bull case for consumer goods stocks
CNBC’s Jim Cramer on Wednesday told investors to consider adding shares of well-established consumer packaged-goods companies to their portfolios. “Nobody’s championing what actually...
SoFi, Nucor, Starbucks, CSX & more
Check out the companies making headlines in premarket trading Wednesday. Starbucks – Shares of Starbucks gained nearly 1% after the company boosted its long-term forecast and said it expects double-di...
Bristol-Myers Squibb, Twitter, Gilead Sciences and more
Check out the companies making the biggest moves midday Monday: Gilead Sciences — Shares of Gilead rose 3.8% after the biopharmaceutical company revealed it settled a patent case over its HIV therapie...
Carvana, Bristol-Myers Squibb, Alphatec and more
Ernie Garcia, CEO, Carvana Scott Mlyn | CNBC Check out the companies making headlines before the bell Monday. Carvana — Shares of the online car seller rose more than 7% in the premarket after Piper S...
Stocks making biggest midday moves: Netflix, Bristol-Myers and more
The Netflix logo is seen on a TV remote controller, in this illustration taken January 20, 2022. Dado Ruvic | Reuters Check out the companies making headlines in midday trading. Catalent Inc. – Shares...
Passage of Inflation Reduction Act gives Medicare historic new powers
A pharmacist collects medications for prescriptions at a pharmacy. Simon Dawson | Bloomberg | Getty Images Medicare is poised to renegotiate the prices of some of its most expensive drugs through a hi...
Having women in the boardroom or C-suite drives diversity, study finds
shironosov | Getty Images If you want to take a good guess at a company’s gender diversity record, you might want to first look at who its CEO or board chair is, according to the findings of a n...
Here’s Jim Cramer’s advice to navigate this uncertain earnings season
Earnings season is entering full swing on Wall Street, and CNBC’s Jim Cramer said Monday that investors would be wise to take a wait-and-see approach toward shares of companies that are about to...
Turning Point Therapeutics, Lululemon, RH and others
Check out the companies making headlines before the bell: Turning Point Therapeutics (TPTX) – The biopharmaceutical company’s shares more than doubled in premarket trading after agreeing to be a...
Warren Buffett’s Berkshire Hathaway reveals new stakes in Paramount, Citigroup
OMAHA, Neb. — Warren Buffett’s company on Monday revealed all the investment moves it made in the first quarter, when it spent more than $51 billion on stocks. But Buffett had already shared the bigge...
Robinhood, Amazon, Apple, Roku and more
Vlad Tenev, CEO and co-founder Robinhood Markets, Inc., is displayed on a screen during his company’s IPO at the Nasdaq Market site in Times Square in New York City, U.S., July 29, 2021. Brendan McDer...
Senate confirms Biden FDA pick Califf, despite objections to drug industry ties
Robert Califf testifies during the Senate Health, Education, Labor and Pensions Committee hearing on the nomination to be commissioner of the Food and Drug Administration on Tuesday, Dec. 14, 2021. Bi...
Amazon, Snap, Ford and more
Check out the companies making headlines before the bell: Regeneron Pharmaceuticals (REGN) – The drugmaker reported adjusted quarterly earnings of $23.72 per share, beating the $18.35 consensus estima...
10 defensive stocks that can also provide you with growth and dividends over the long term
The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet. Mark Hulbert has called the recent...